Biocompatible Coated Tungstate Nanoparticles for Targeted Radiotherapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current radio-sensitization methods for cancer treatment, such as anticancer drugs and photoelectric nanoparticles, are toxic and inefficient, limiting the effectiveness of radiation therapy and causing significant side effects, while existing nanoparticle formulations for Radio Luminescence Therapy (RLT) are not suitable for in vivo applications due to instability and toxicity.
Innovation Solution
Development of biocompatible polymeric coatings for metal tungstate and molybdate nanoparticles, specifically encapsulating calcium tungstate (CaWO4) and other metal tungstates within amphiphilic block copolymer micelles to enhance stability, biocompatibility, and targeting capabilities, allowing for efficient delivery to cancer cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current radio-sensitization methods (anticancer drugs or photoelectric nanoparticles) are used, then cancer cells can be targeted, but toxicity increases and treatment efficiency decreases
Solution Approach 1:
The invention changes the fundamental parameter of the radio-sensitizer material from conventional anticancer drugs or photoelectric nanoparticles to radio-luminescent particles (RLPs) based on metal tungstates and metal molybdates. These RLPs absorb ionizing radiation and convert it to UV light, creating a new mechanism of action that is inherently less toxic to healthy cells while maintaining or improving cancer cell targeting effectiveness
Solution Approach 2:
The invention introduces radio-luminescent particles as an intermediary substance that mediates between the ionizing radiation and the cancer cells. The RLPs absorb the radiation and convert it to UV light, which then interacts with the cancer cells to produce therapeutic effects. This intermediary approach allows for more controlled and localized energy delivery, reducing collateral damage to healthy tissues
2Productivity
If radio-luminescent nanoparticles are used for RLT, then radiation therapy efficiency improves, but colloidal stability and biocompatibility deteriorate
Solution Approach 1:
The invention creates composite nanoparticle structures by combining radio-luminescent particles (metal tungstates or metal molybdates) with biocompatible coating materials. The core RLPs provide the radio-luminescent function for efficient radiation therapy, while the biocompatible coating shell provides colloidal stability and biocompatibility. This core-shell composite structure allows both high radiation therapy efficiency and stable biological performance to coexist
Solution Approach 2:
The invention applies biocompatible coating materials as protective shells around the radio-luminescent particles. These coating shells provide steric stabilization and prevent aggregation of the nanoparticles in physiological environments, thereby ensuring colloidal stability. The thin film coating does not significantly interfere with the radio-luminescent properties of the core particles while providing necessary biological compatibility
3Productivity
If radio-luminescent nanoparticles are used for RLT, then radiation therapy efficiency improves, but biocompatibility deteriorates
Solution Approach 1:
The invention creates composite nanoparticle structures by combining radio-luminescent particles (metal tungstates or metal molybdates) with biocompatible coating materials. The core RLPs provide the radio-luminescent function for efficient radiation therapy, while the biocompatible coating shell provides colloidal stability and biocompatibility. This core-shell composite structure allows both high radiation therapy efficiency and stable biological performance to coexist
Solution Approach 2:
The biocompatible coating material serves as an intermediary layer between the potentially toxic metal tungstate/molybdate core and the biological environment. This coating shell prevents direct interaction between the metal particles and biological tissues, reducing toxicity while allowing the radio-luminescent function to operate effectively
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The encapsulated nanoparticles demonstrate improved colloidal stability, biocompatibility, and enhanced luminescence properties, enabling effective and targeted radio-luminescent therapy with reduced side effects by delivering therapeutic doses of radiation directly to cancer cells while minimizing exposure to healthy tissues.
Implementation Method 1
This technology is based on a new type of radio-sensitizer, namely, 'Radio-Luminescent Particles (RLPs)'. The most promising examples of such materials include metal tungstates and metal molybdates. These RLPs produce UV light with high energy photon radiation.
Data Source
Figure 1
Figure 2
Figure 3A~3C
AI summary
The invention relates generally to a formulation in which metal tungstate or metal molybdate particles are encapsulated within biocompatible, diseased cell-targeting polymeric coatings. Such formulations render metal tungstate or metal molybdate particles suitable for in vivo biomedical imaging and therapeutic applications.